Dopamine nerve function probe captures "clues" of Parkinson's disease

"Using fluorodopa PET imaging equipment to detect dopaminergic neurons can greatly improve the accuracy of early diagnosis of Parkinson's disease and reduce the misdiagnosis and treatment of patients.

Currently, clinical observations of diseases are more at the cellular structure level, but the cellular and molecular state level can predict disease trends earlier and accurately, which has become an important trend in the development of precision medicine.

The aging of our country has been accelerating.

Ten years ago, Zhang Xiangsong took the lead in exploring the use of nuclear medicine to achieve early diagnosis of Parkinson's disease.

Zhang Xiangsong introduced that the use of probes to detect dopamine nerve function clinically can detect whether the patient's dopamine nerve function is damaged by nuclear medicine imaging 10-20 years before the motor symptoms of Parkinson's disease patients appear.